Cargando…

Persistence of the SARS-CoV-2 Antibody Response in Asymptomatic Patients in Correctional Facilities

SARS-CoV-2 has caused a global health disaster with millions of death worldwide, and the substantial proportion of asymptomatic carriers poses a huge threat to public health. The long-term antibody responses and neutralization activity during natural asymptomatic SARS-CoV-2 infection are unknown. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Xiaodong, Jiang, Wenguo, Zhang, He, Lu, XiXi, Li, Libo, Liu, Wenjun, Li, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631518/ https://www.ncbi.nlm.nih.gov/pubmed/34858383 http://dx.doi.org/10.3389/fmicb.2021.789374

Ejemplares similares

Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals
por: Brochot, Etienne, et al.
Publicado: (2020)

Potent and Persistent Antibody Response in COVID-19 Recovered Patients
por: Tian, Xiaodong, et al.
Publicado: (2021)

Asymptomatic SARS-CoV-2 infected patients with persistent negative CT findings
por: Ling, Zhoukun, et al.
Publicado: (2020)

Viral dynamics and antibody responses in people with asymptomatic SARS-CoV-2 infection
por: Sui, Zhiwei, et al.
Publicado: (2021)

Persistent SARS-CoV-2 infection in asymptomatic young adults
por: Ma, Mai-Juan, et al.
Publicado: (2022)

The Utility of Specific Antibodies Against SARS-CoV-2 in Laboratory Diagnosis
por: Fu, Yu, et al.
Publicado: (2021)

Nasopharyngeal Bacterial Microbiota Composition and SARS-CoV-2 IgG Antibody Maintenance in Asymptomatic/Paucisymptomatic Subjects
por: Ferrari, Luca, et al.
Publicado: (2022)

A versatile integrated tube for rapid and visual SARS-CoV-2 detection
por: Xu, Jingsong, et al.
Publicado: (2023)

Review of therapeutic mechanisms and applications based on SARS-CoV-2 neutralizing antibodies
por: Liu, Mingtao, et al.
Publicado: (2023)

Saliva Quantification of SARS-CoV-2 in Real-Time PCR From Asymptomatic or Mild COVID-19 Adults
por: Carrouel, Florence, et al.
Publicado: (2022)

Profile of specific antibodies to the SARS-CoV-2
por: Mou, Danlei, et al.
Publicado: (2021)

Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses
por: Yang, Yong, et al.
Publicado: (2021)

Asymptomatic SARS-CoV-2 infection in Belgian long-term care facilities
por: Hoxha, Ana, et al.
Publicado: (2021)

Prolonged Persistence of SARS-CoV-2 RNA in Body Fluids
por: Sun, Jiufeng, et al.
Publicado: (2020)

Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2
por: Meyerowitz, Eric A, et al.
Publicado: (2021)

Viral Shedding and Persistence of Anosmia and Ageusia in an Asymptomatic SARS-CoV-2 Infection
por: Kintrilis, Nikolaos
Publicado: (2023)

Neutralizing antibody response to SARS-CoV-2 persists 9 months post symptom onset in mild and asymptomatic patients
por: Bylicki, Olivier, et al.
Publicado: (2021)

Saliva TwoStep for rapid detection of asymptomatic SARS-CoV-2 carriers
por: Yang, Qing, et al.
Publicado: (2021)

Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Li, Jin-Yan, et al.
Publicado: (2021)

Clinical characteristics of patients with confirmed and asymptomatic SARS-CoV-2 infection in China
por: Li, Zongren, et al.
Publicado: (2022)

Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection
por: Choe, Pyoeng Gyun, et al.
Publicado: (2021)

Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies
por: Dufloo, Jérémy, et al.
Publicado: (2021)

Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection
por: Marchi, Serena, et al.
Publicado: (2021)

Symptomatic and Asymptomatic SARS-CoV-2 Infection and Follow-up of Neutralizing Antibody Levels
por: CUI, Shu Juan, et al.
Publicado: (2022)

Persistence of SARS-CoV-2-specific antibodies in COVID-19 patients
por: Wang, Yanan, et al.
Publicado: (2021)

The Potential Intermediate Hosts for SARS-CoV-2
por: Zhao, Jie, et al.
Publicado: (2020)

A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual
por: Caccuri, Francesca, et al.
Publicado: (2020)

SARS-CoV-2 Nucleocapsid Protein Has DNA-Melting and Strand-Annealing Activities With Different Properties From SARS-CoV-2 Nsp13
por: Zhang, Bo, et al.
Publicado: (2022)

Enlightenments of Asymptomatic Cases of SARS-CoV-2 Infection
por: Wang, Jingbo, et al.
Publicado: (2020)

SARS-CoV-2 Causes Mitochondrial Dysfunction and Mitophagy Impairment
por: Shang, Chao, et al.
Publicado: (2022)

Non-structure protein ORF1ab (NSP8) in SARS-CoV-2 contains potential γδT cell epitopes
por: Du, Boyu, et al.
Publicado: (2022)

Inactivated Vaccines Against SARS-CoV-2: Neutralizing Antibody Titers in Vaccine Recipients
por: Zhang, Haiying, et al.
Publicado: (2022)

RNA SARS-CoV-2 Persistence in the Lung of Severe COVID-19 Patients: A Case Series of Autopsies
por: Caniego-Casas, Tamara, et al.
Publicado: (2022)

Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Rehabilitation Facility: Evolution of the Presence of Nasopharyngeal SARS-CoV-2 and Serological Antibody Responses
por: Harris, Benjamin H L, et al.
Publicado: (2020)

Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients
por: Choe, Pyoeng Gyun, et al.
Publicado: (2020)

Comparative analysis of antibodies to SARS-CoV-2 between asymptomatic and convalescent patients
por: Dwyer, Connor J., et al.
Publicado: (2021)

Antibody and T Cell Immune Responses to SARS-CoV-2 Peptides in COVID-19 Convalescent Patients
por: Garanina, Ekaterina, et al.
Publicado: (2022)

Persistence of SARS-CoV-2 antibodies in kidney transplant recipients
por: Benotmane, Ilies, et al.
Publicado: (2021)

Rapid and Specific Detection of Active SARS-CoV-2 With CRISPR/Cas12a
por: Liu, Xinyi, et al.
Publicado: (2022)

The BBIBP-CorV inactivated COVID-19 vaccine induces robust and persistent humoral responses to SARS-CoV-2 nucleocapsid, besides spike protein in healthy adults
por: Wang, Qinjin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p45s9s8u355pimg7habblf4rde